TABLE 4.
Cumulative and Per-month Calculated Payments, by Chemoradiation Regimen
| Cumulative (in 2014 US Dollars) | Payments Per Month (in 2014 US Dollars) | |||||||
|---|---|---|---|---|---|---|---|---|
| Median Chemoradiation Payments (IQR) | Median Hospitalization Payments (IQR) | Median Chemoradia- tion Payments (IQR) | Median Hospitalization Payments (IQR) | |||||
| Capecitabine + radiation | 19,294 | (4955–54,606) | 39,797 | (17,182–93,487) | 1293 | (343–8916) | 2660 | (963–8916) |
| Gemcitabine + radiation | 46,074 | (21,674–85,749) | 32,335 | (14,865–69,640) | 3191 | (1595–5250) | 2363 | (1001–5250) |
| FOLFIRINOX + radiation | 95,336 | (57,403–154,784) | 39,991 | (20,408–83,575) | 6427 | (3731–10,587) | 2472 | (997–5370) |
| Gemcitabine | 39,041 | (17,836–70,295) | 32,255 | (14,098–69,582) | 2811 | (1394–5312) | 2400 | (1001–5312) |
| Gemcitabine + nab-paclitaxel | 74,051 | (38,929–133,603) | 31,751 | (15,068–71,783) | 4951 | (2276–5736) | 2268 | (997–5736) |
| FOLFIRINOX | 70,419 | (35,662–123,078) | 42,951 | (25,555–83,575) | 7149 | (3485–10,972) | 4414 | (1520–10,972) |
| Overall | 39,098 | (13,304–76,034) | 31,751 | (15,418–69,615) | 2824 | (1186–5785) | 2360 | (971–5785) |